Chronic Branch Retinal Vein Occlusion: What Patients Need to Know
Understanding Branch Retinal Vein Occlusion
BRVO is a condition that affects the blood vessels inside the eye. It occurs when one of the small veins that drain blood from the retina becomes blocked, disrupting normal blood flow and causing damage to the surrounding tissue.
The retina is the light-sensitive tissue lining the back of the eye. It captures images and sends visual signals to the brain. The retina has a network of small veins that carry blood away from it. When one of these branch veins becomes blocked, blood cannot drain properly, pressure builds up, and fluid or blood can leak into the surrounding retinal tissue.
Most BRVO blockages form at a point where a retinal artery and a vein cross over each other. These two vessels share a common outer sheath at the crossing. When the artery stiffens due to atherosclerosis, which is the hardening and narrowing of artery walls, it compresses the underlying vein. This compression disrupts blood flow and promotes clot formation, eventually leading to a blockage.
Once the vein is blocked, blood cannot drain from that section of the retina, and two main problems can follow. First, fluid may leak into the macula, which is the central area of the retina responsible for sharp, detailed vision. This swelling is called macular edema. Second, the blocked area may receive insufficient oxygen-rich blood, a condition called ischemia, which can lead to further complications if not addressed.
In some cases, the body creates alternative drainage pathways called collateral vessels, and the condition partially resolves on its own. However, when the blockage persists or retinal damage is significant, the condition is considered chronic. Chronic BRVO means that macular edema, ischemia, or both continue over months or years, requiring ongoing monitoring and often repeated treatment to protect vision.
Who Is at Risk
BRVO is one of the most common retinal vascular diseases, and certain health conditions increase the likelihood of developing it. Understanding these risk factors can help guide both prevention and early detection.
BRVO affects a meaningful portion of the adult population and becomes more common with age. It occurs in men and women at roughly similar rates, though the risk rises significantly with each decade of life, particularly after age 50.
Most risk factors for BRVO are related to cardiovascular and blood vessel health. Addressing these factors is an important part of both prevention and long-term management.
- Uncontrolled high blood pressure, particularly elevated diastolic blood pressure
- Cardiovascular disease, including coronary artery disease or a history of stroke
- Being overweight or obese
- Age over 50 years
- A history of glaucoma, which is elevated pressure inside the eye
Research has found that both age and elevated diastolic blood pressure are statistically significant risk factors for retinal vein occlusion. Studies have also found that Black individuals face a meaningfully higher risk of developing BRVO compared to non-Hispanic white individuals, which underscores the importance of proactive screening for all high-risk groups.
Recognizing the Signs and Symptoms
BRVO does not always cause obvious symptoms right away, which makes routine eye examinations important for early detection. When symptoms do appear, they often involve a change in part of the visual field rather than complete vision loss.
The most typical symptom of BRVO is sudden, painless vision loss or blurriness affecting a portion of the visual field. This may happen all at once or may worsen over several hours or days. Some people notice a blurry or darkened area in their vision, while others experience a more general decline in visual clarity.
If the blocked vein supplies an area of the retina away from the macula, BRVO may produce no noticeable symptoms at all. In these cases, the condition can go undetected for months and may only be found during a routine dilated eye examination. This is one important reason to maintain regular eye exams, especially for people over 50 or those with known risk factors for vascular disease.
Chronic BRVO can sometimes trigger the growth of abnormal new blood vessels on the retina, a process called neovascularization. These fragile vessels can break and bleed into the vitreous, which is the gel-like substance filling the inside of the eye. This may cause a sudden increase in floaters or a rapid darkening of vision and requires prompt evaluation by a retina specialist.
How BRVO Is Diagnosed
Diagnosing BRVO involves a combination of eye imaging, clinical examination, and often a review of overall cardiovascular health. Our retina team uses advanced diagnostic tools at every stage of care.
A retina specialist begins with a thorough dilated eye exam. Special drops widen the pupil so the specialist can see the retina in detail. In BRVO, the exam typically reveals a characteristic pattern of retinal hemorrhages, or bleeding, that follows the path of the blocked vein in a wedge or fan shape, with the narrow end pointing toward the crossing where the blockage occurred.
Optical coherence tomography, known as OCT, is a noninvasive imaging test that produces highly detailed cross-section images of the retinal layers. OCT is the primary tool used to detect and measure macular edema, showing the precise amount of fluid buildup within the retina. Our specialists use OCT at nearly every follow-up visit to track how the retina responds to treatment and to decide when additional therapy is needed.
Fluorescein angiography involves injecting a special dye into a vein in the arm. As the dye circulates through the retinal blood vessels, a camera takes rapid sequential photographs. This test reveals the location and extent of the blockage, areas of poor blood flow (ischemia), leaking vessels, and any signs of neovascularization. It provides a detailed map of circulation in the affected area of the retina.
Because BRVO is closely tied to cardiovascular health, a retina specialist will often recommend blood pressure monitoring and coordination with a primary care provider. Blood tests may be ordered to assess cholesterol, blood sugar, and other markers of vascular risk. Managing these underlying conditions is an essential part of the overall treatment plan for chronic BRVO.
Treatment Options for Chronic BRVO
Several effective treatments are available for managing chronic BRVO. The right approach depends on the severity of macular edema, the presence of complications, and each patient's overall health and treatment history. Our retina specialists, including Gaurav Gupta, M.D. and Pranjal Thakuria, M.D., work closely with each patient to build a personalized plan.
Anti-VEGF therapy is the first-line treatment for macular edema caused by BRVO. VEGF stands for vascular endothelial growth factor, a protein that drives abnormal blood vessel growth and fluid leakage. Anti-VEGF medications are injected directly into the eye to block this protein, reduce swelling, and help preserve or improve vision. Several options are currently approved for treating macular edema from retinal vein occlusion.
- Lucentis (ranibizumab), approved for retinal vein occlusion, typically given every four weeks
- Eylea (aflibercept), approved for BRVO, given every four to eight weeks after initial loading doses
- Vabysmo (faricimab), a bispecific antibody that blocks both VEGF-A and angiopoietin-2, approved for retinal vein occlusion
- Eylea HD (high-dose aflibercept), a newer formulation that allows for less frequent dosing intervals
- Avastin (bevacizumab), approved for cancer treatment and used off-label for eye conditions, typically given every four to six weeks
When chronic BRVO leads to neovascularization, scatter laser photocoagulation may be recommended. This thermal laser treatment is applied to the affected area of the retina, reducing its demand for oxygen and helping stop the growth of abnormal new blood vessels. Research has shown this approach significantly reduces neovascularization-related complications in BRVO patients. It is typically used alongside anti-VEGF therapy when neovascularization develops.
For patients who do not respond well to anti-VEGF therapy, or who find frequent injection visits difficult to maintain, steroid-based treatments may be considered. Ozurdex (dexamethasone implant) is a small, biodegradable implant placed inside the eye that slowly releases medication over several months to reduce macular edema. Steroid treatments carry a higher risk of elevated eye pressure and cataract formation, so our retina specialists carefully weigh the benefits and risks for each individual patient.
Multiple biosimilar medications have been approved in recent years for treating macular edema related to retinal vein occlusion. Biosimilars are medications that are highly similar to existing approved anti-VEGF drugs and are designed to offer equally effective treatment. Our specialists can discuss whether a biosimilar is an appropriate part of your treatment plan.
What to Expect During Treatment
Understanding what the treatment process looks like can help ease concerns about getting started. Most patients find the experience manageable, and our team works to make each visit as comfortable as possible.
Intravitreal injections are performed in our office setting. The eye is numbed with anesthetic drops and cleaned with an antiseptic solution before a very fine needle is used to deliver the medication into the vitreous cavity. The procedure takes only a few minutes. Most patients feel pressure or mild discomfort, and it is common to experience temporary floaters, mild redness, or a gritty sensation afterward that typically resolves within a day or two.
Treating chronic BRVO usually requires multiple injections over an extended period of time. Most anti-VEGF plans begin with a series of monthly loading doses. After this initial phase, the interval between injections may be extended based on how the macular edema responds. Newer agents such as Eylea HD and Vabysmo offer the possibility of longer intervals between treatments, which can reduce the overall burden on patients. OCT imaging at each visit guides decisions about timing and dosing.
Many patients with chronic BRVO experience meaningful improvement in vision with consistent treatment, though outcomes vary from person to person. The degree of improvement depends on how long macular edema has been present, the extent of ischemia, and how quickly treatment begins. Some patients achieve significant vision gains, while others stabilize their vision and prevent further loss. Our team will set realistic expectations with you based on your specific situation.
Living Well With Chronic BRVO
Managing chronic BRVO goes beyond the eye clinic. Taking an active role in your overall vascular health plays a meaningful role in protecting your vision over time.
Controlling high blood pressure is the single most important modifiable step for patients with BRVO, as hypertension is the leading contributing risk factor. Working with a primary care provider to maintain healthy blood pressure, cholesterol, and blood sugar levels can reduce the risk of further vascular events affecting the eye or other parts of the body.
Healthy daily habits support overall vascular health and may reduce the risk of BRVO worsening or developing in the other eye. Small, consistent changes can make a real difference over time.
- Maintain a healthy weight through balanced nutrition and regular physical activity
- Follow a heart-healthy diet rich in fruits, vegetables, whole grains, and lean proteins
- Avoid smoking, as tobacco use damages blood vessels throughout the body
- Take all prescribed blood pressure and cholesterol medications as directed by your doctor
- Keep all scheduled follow-up appointments with your retina specialist
Patients with chronic BRVO should pay close attention to any changes in their vision between appointments. Using an Amsler grid, which is a simple chart with a grid pattern designed to help detect changes in central vision, can be a useful daily tool. If new or worsening symptoms appear, including increased blurriness, new floaters, or a dark area in the visual field, contact your retina specialist promptly. Early detection of changes gives treatment the best chance of preventing further damage.
When to See a Retina Specialist
Knowing when to seek care, and how urgently, is an important part of managing this condition. Some situations require immediate attention, while others can be addressed at a scheduled visit.
Certain symptoms associated with BRVO require same-day or emergency evaluation. If you experience any of the following, seek care right away rather than waiting for a routine appointment.
- A sudden increase in floaters or new floaters appearing without explanation
- Flashes of light in your vision
- A curtain, shadow, or dark area spreading across part of your visual field
- Sudden vision loss in one eye
Even when chronic BRVO appears stable, regular follow-up appointments are essential. A retina specialist will use OCT and other imaging to monitor for macular edema recurrence and to check for signs of neovascularization. Visit frequency depends on the severity of the condition and the current treatment plan. Some patients are seen every few weeks during active treatment, while those on extended intervals may visit every few months.
If vision continues to decline despite treatment or if there are concerns about the current treatment approach, seeking a second opinion from another retina specialist is a reasonable step. Chronic BRVO can be complex, and treatment strategies can vary. Getting additional input can provide reassurance or surface alternative options that may better fit your needs.
Frequently Asked Questions
These answers address common questions patients have about living with and managing chronic BRVO that go beyond the general information covered above.
BRVO typically affects one eye at a time rather than both simultaneously. However, because the underlying risk factors, such as high blood pressure and atherosclerosis, affect blood vessels throughout the entire body, there is a real risk that BRVO could eventually develop in the other eye as well. This is why managing cardiovascular health proactively is so important, not just for the affected eye, but for your overall long-term eye health.
Treatment duration is different for every patient and is determined visit by visit based on how the macula responds. Some patients need injections for several months, while others require treatment for years. It is also important to understand that stopping injections without guidance from your retina specialist can allow macular edema to return, sometimes causing significant vision setbacks. Your specialist will help you determine when it may be safe to extend or pause treatment.
Currently, there is no single treatment that permanently resolves chronic BRVO. The blocked vein often remains, and macular edema can return if treatment is paused or stopped. The goal of care is to control fluid leakage, preserve functional vision, and prevent serious complications like neovascular glaucoma or vitreous hemorrhage. For most patients, this means an ongoing partnership with their retina specialist over the long term.
Without treatment, persistent macular edema can progressively damage the delicate retinal cells needed for reading, recognizing faces, and other central vision tasks. Over time, this damage may become permanent. Untreated ischemia can also trigger neovascularization, which may lead to vitreous hemorrhage, tractional retinal detachment (where scar tissue pulls the retina away from its normal position), and neovascular glaucoma, all of which are serious and vision-threatening complications.
While lifestyle changes cannot reverse an existing retinal vein occlusion, they directly address the cardiovascular risk factors that contributed to it. Lowering blood pressure, maintaining a healthy weight, and improving vascular fitness through regular physical activity reduce stress on the retinal blood vessels. These changes work alongside medical treatment and may meaningfully lower the risk of future vascular events in either eye.
The primary measure of treatment success is whether macular edema is decreasing, which is assessed using OCT imaging at each visit. Your vision test results at appointments also provide important information. Keep in mind that vision improvement can be gradual and may not feel dramatic from one visit to the next. Consistent attendance at follow-up appointments is the best way to ensure your specialist has the information needed to adjust your care in a timely way.
Care for Chronic BRVO at Rhode Island Eye Institute
Our retina specialists, including Gaurav Gupta, M.D. and Pranjal Thakuria, M.D., bring subspecialty expertise and compassionate care to every patient facing chronic BRVO. We use advanced diagnostic imaging and the latest approved therapies to help preserve and protect your vision for the long term. If you are experiencing symptoms or have been diagnosed with BRVO, we invite you to schedule a visit with our team and take the next step toward confident, expert-guided care.